Compare Oxford Lane Capital Corp (OXLC) vs Select Medical Holdings Corporation (SEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oxford Lane Capital Corp vs Select Medical Holdings Corporation — how do they compare? Oxford Lane Capital Corp trades at $8.84 (market cap $861.22M), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Select Medical Holdings Corporation is far larger — about 2.4× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays the higher dividend (27.21%). Which is the better fit depends on your goals.
| OXLC | SEM | |
|---|---|---|
Market Cap | $861.22M | $2.05B |
Sector | Financials | Health |
52-Week High | $19.90 | $16.66 |
52-Week Low | $8.15 | $11.77 |
Dividend Yield | 27.21% | 1.51% |
Enterprise Value | — | $5.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OXLC trades at $8.87, up 1.14% today, but faces a bearish technical outlook with significant selling pressure. The company reported a net income of $48.46 million for 2025, but recent quarterly earnings have consistently missed expectations, including a substantial miss in Q1 2026. Despite a high dividend yield, financial performance shows strain with negative ROE and ROA, while cash flow is heavily dependent on financing activities.
The outlook is cautious due to deteriorating fundamentals, negative profitability metrics, and bearish analyst sentiment. The primary opportunity lies in the high dividend yield, but risks include unsustainable distributions, declining net asset value, and potential for further earnings volatility. Investor caution is warranted given the conflicting signals between dividend income and underlying financial health.
Select Medical (SEM) trades at $16.51, unchanged on the day, amid a completed acquisition by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock shows a bullish technical signal with support and resistance clustered around $17. Financially, the company reported 2025 revenue of $5.45B and net income of $146.22M, with a P/E of 15.43 and P/S of 0.36 indicating moderate valuation. Recent earnings have been mixed, with a beat in Q3 2025 but misses in Q4 2025 and Q1 2026.
The acquisition at $16.50 per share caps near-term upside, with legal investigations into the board's fiduciary duties posing a key risk. Analyst sentiment is mixed with 35.71% buy ratings but 57.15% hold, reflecting uncertainty post-buyout. Investors should note the stock's limited movement potential given the acquisition price, with fundamental performance and legal outcomes driving any residual value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →
